Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.87 USD | +4.01% | +7.18% | +13.30% |
Apr. 18 | Alx Oncology Holdings Insider Sold Shares Worth $710,195, According to a Recent SEC Filing | MT |
Apr. 10 | ALX Oncology Reports Positive Data From Ongoing Phase 1/2 Trial of Evorpacept | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.30% | 852M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.23% | 22.02B | |
-17.84% | 20.9B | |
-9.37% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- ALXO Stock
- News ALX Oncology Holdings Inc.
- ALX Oncology Holdings Files $450 Million Mixed Shelf